NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,173 | +0.9% | 11,511 | 0.0% | 0.12% | +3.4% |
| Q2 2023 | $1,162 | +9.6% | 11,511 | -0.1% | 0.12% | +2.6% |
| Q1 2023 | $1,060 | -0.1% | 11,523 | -1.5% | 0.12% | -6.5% |
| Q4 2022 | $1,061 | -99.9% | 11,698 | -4.8% | 0.12% | +1.7% |
| Q3 2022 | $934,000 | -13.4% | 12,288 | -3.7% | 0.12% | -9.0% |
| Q2 2022 | $1,079,000 | -34.0% | 12,761 | -31.5% | 0.13% | -24.9% |
| Q1 2022 | $1,634,000 | -88.9% | 18,622 | -89.0% | 0.18% | -88.0% |
| Q4 2021 | $14,756,000 | -15.1% | 168,702 | -20.6% | 1.48% | -27.1% |
| Q3 2021 | $17,376,000 | -7.6% | 212,475 | +3.1% | 2.03% | -6.4% |
| Q2 2021 | $18,797,000 | +8.2% | 206,020 | +1.4% | 2.17% | +1.9% |
| Q1 2021 | $17,366,000 | -8.5% | 203,159 | +1.0% | 2.12% | -11.8% |
| Q4 2020 | $18,987,000 | +10.8% | 201,069 | +2.0% | 2.41% | -0.7% |
| Q3 2020 | $17,139,000 | +0.0% | 197,088 | +0.5% | 2.42% | -7.1% |
| Q2 2020 | $17,132,000 | +3.3% | 196,154 | -2.5% | 2.61% | -14.5% |
| Q1 2020 | $16,591,000 | -10.2% | 201,220 | +3.1% | 3.05% | +10.5% |
| Q4 2019 | $18,476,000 | +8.0% | 195,119 | -0.9% | 2.76% | +0.4% |
| Q3 2019 | $17,107,000 | -6.0% | 196,863 | -1.2% | 2.75% | -8.9% |
| Q2 2019 | $18,194,000 | -4.4% | 199,258 | +0.7% | 3.02% | -7.3% |
| Q1 2019 | $19,025,000 | +12.5% | 197,890 | +0.4% | 3.26% | -0.5% |
| Q4 2018 | $16,916,000 | -0.7% | 197,136 | -0.3% | 3.28% | +13.9% |
| Q3 2018 | $17,043,000 | +14.5% | 197,807 | +0.3% | 2.88% | +5.1% |
| Q2 2018 | $14,891,000 | -5.6% | 197,130 | +1.0% | 2.74% | -5.1% |
| Q1 2018 | $15,775,000 | -3.9% | 195,112 | -0.2% | 2.88% | -0.8% |
| Q4 2017 | $16,419,000 | -2.5% | 195,556 | -0.3% | 2.90% | -8.8% |
| Q3 2017 | $16,836,000 | +0.0% | 196,115 | -2.8% | 3.18% | -2.5% |
| Q2 2017 | $16,833,000 | +12.6% | 201,665 | +0.2% | 3.26% | +11.5% |
| Q1 2017 | $14,951,000 | +5.9% | 201,310 | +3.9% | 2.93% | -0.1% |
| Q4 2016 | $14,116,000 | -7.7% | 193,798 | +0.1% | 2.93% | -10.5% |
| Q3 2016 | $15,291,000 | -3.5% | 193,652 | +0.8% | 3.27% | -8.1% |
| Q2 2016 | $15,851,000 | +15.9% | 192,115 | +1.7% | 3.56% | +10.7% |
| Q1 2016 | $13,678,000 | -11.8% | 188,823 | +4.8% | 3.22% | -20.4% |
| Q4 2015 | $15,508,000 | -6.8% | 180,240 | -0.5% | 4.04% | -12.8% |
| Q3 2015 | $16,646,000 | -5.4% | 181,095 | +1.3% | 4.64% | +4.7% |
| Q2 2015 | $17,588,000 | +1.6% | 178,845 | +1.9% | 4.43% | +4.7% |
| Q1 2015 | $17,306,000 | +7.1% | 175,502 | +0.6% | 4.23% | +10.8% |
| Q4 2014 | $16,160,000 | -0.6% | 174,404 | +1.0% | 3.82% | -1.7% |
| Q3 2014 | $16,255,000 | +2.6% | 172,690 | -1.4% | 3.89% | +3.0% |
| Q2 2014 | $15,849,000 | +7.4% | 175,065 | +0.9% | 3.77% | +0.7% |
| Q1 2014 | $14,756,000 | +6.5% | 173,558 | +0.7% | 3.75% | +7.0% |
| Q4 2013 | $13,858,000 | +11.5% | 172,411 | +6.4% | 3.50% | +2.7% |
| Q3 2013 | $12,431,000 | +10.2% | 162,054 | +1.6% | 3.41% | +1.9% |
| Q2 2013 | $11,281,000 | – | 159,539 | – | 3.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |